Document:

EX-10.7(B)

 Exhibit10.7(B) 

CERTAIN CONFIDENTIAL INFORMATION INDICATED BY “[***]” HAS BEEN OMITTED FROM THE FILED COPY OF THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT
MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED 
 Amendment no. 1 

to the Master Service Agreement on Order to Cash Service 

THIS AMENDMENT (hereinafter the “Amendment”) to the Master Service Agreement on Order to cash Service with an effective date
of 1st September 2018 (the “Agreement”), is made on this 1st March 2021 (the “Amendment Signing Date” and made retroactively effective as of 1st day of February, 2021 (the “Amendment Effective
Date”) by and between: 
 APR APPLIED PHARMA RESEARCH S.A., a company incorporated in Switzerland, having its principal place
of business at Via Corti, 5, 6828 Balerna (“APR”); 
 AND 

ARVATO SERVICES ITALIA SRL a corporation having its registered office at Via Zanica, 19K, 24050 Grassobbio (BG), Italy
(“ARVATO”) 
 Each of the above is a “Party” and together referred to herein as the “Parties”. 

Preamble 
 APR expressed its interest in
renegotiating the actual Agreement, based on actual business and updated forecast provided and in accordance with the provision of Article 19, par (2) of the Agreement. 

Arvato agreed on the same and the Parties met in good faith in order to find a mutual solution to proceed with the business. 

Therefore, this Amendment modifies the initial provided services by Arvato to APR and updates the economics and forecast present in Schedule D and
Schedule E of the present Agreement. 
 Notwithstanding the above, the Parties are still discussing about the possibility to apply other changes to
this Agreement and, for this reason, the Parties intend to extend the negotiation period required by Article 19 par (2), in order to try and reach a modification of the Agreement in good faith until the term of July 1st, 2021. 

Capitalized terms not otherwise defined herein shall have the meaning given to them in the Agreement. Except as modified below, the terms of the Agreement
shall remain in full force and effect. 
 In consideration of the mutual obligations set out herein, the Parties hereby agree that the terms and conditions
set out below shall be added as an Amendment to the Agreement. Except where the context requires otherwise, references in this Amendment to the Agreement are to the Agreement as amended by, and including, this Amendment. 

 Amendment Terms and Conditions 

 

	1.	 Order to Invoice System. It is agreed between the Parties that the services business model in place
starting with the Amendment Effective Date will be the “Order to Invoice”, instead of actual “Order to Cash”. For the avoidance of doubt, ARVATO shall not be anymore responsible for the activities related to the payment of the
invoices by Customers to APR. 

  

	2.	 Amendment to Article 9, par (4). The Parties agree that Article 9, par (4) of the
Agreement will be amended with the Article 9, par (4) of this Amendment as follows: 

 “Starting with 1st January 2021, a
bonus/malus mechanism shall apply on the three most critical KPI’s according to the following terms: 
  

	 	•	 	 KPI 1 — orders entered correctly in the system: target is above or equal to [***]% as per BRD (schedule B)

  

	 	•	 	 KPI 2 — Damaged units: target is below or equal to [***]% as per BRD (Schedule B) 

 

	 	•	 	 KPI 3 — on time delivery — Germany/Italy/CH: target is above or equal to [***]% as per BRD (Schedule B)

  

	 	a)	 In the event the cumulated result for KPI 1, measured on semestral basis, will exceed the value of [***]%, a
bonus of plus [***]% shall apply on the total amount of the following semester invoices. Otherwise, if the cumulated result for KPI 1, will be inferior to [***]%, a malus of minus [***]% will apply on the total amount of the following semester
invoices. 

  

	 	b)	 In the event the result for KPI 2, measured each year, shall be inferior to [***]%, a bonus of plus [***]%
shall apply on the total amount of the following year invoices. Otherwise, if the result for KPI 2, will exceed the value of [***]%, a malus of minus 1% will apply on the total amount of the following year invoices. 

 

	 	c)	 In the event the cumulated result for KPI 3, measured on semestral basis, will be included in the value range
[***]%-[***]%, a bonus of plus [***]% shall apply on the total amount of the following semester invoices. Otherwise, if the cumulated result for KPI 3, will be inferior to [***]%, a malus of minus [***]% will apply on the total amount of the
following semester invoices. 

 Arvato shall send cumulated KPI reports on semestral basis, which will be used to evaluate
the Bonus/Malus.” 
  

	3.	 Article 19, par (2)—Extension of the term for agreement renegotiation. The Parties
agree that as of the Amendment Effective Date the renegotiation window provided at the end of the first 28 (twenty-eight) calendar months from the Effective Date, by Article 19 par (2) will be extended from March 1st, 2021 to July 1st, 2021. In
the event the Parties do not reach an agreement on the modification of the Agreement within July 1st, 2021, each Party shall be able to terminate the Agreement with a prior written notice of 6 (six) calendar months. All other paragraphs, terms and
conditions of the Article remain unchanged. 

  
 2 

	4.	 Amendment to Schedule C — FRD Termination 

As agreed between the Parties, the Financial services offered by Arvato to APR are not anymore in scope, starting from the Amendment Effective
Date. As a consequence of the foregoing, the Financial Requirements Document (FRD) executed by APR as Schedule C of the Agreement with date of October 30, 2018 is terminated. 

 

	5.	 Amendment to Schedule D — Updated Pricing and Assumptions 

The Parties agreed to revise the economics of the contract as per updated Schedule D, present in this Amendment, with validity as from
the Amendment Effective Date. 
  

	6.	 Amendment to Schedule E — Updated Forecast 

The Parties agreed to revise the Volumes assumptions of the contract as per updated Schedule E, present in this Amendment, with validity
as from the Amendment Effective Date. 

  
 3 

 AS WITNESS hereto the Parties have caused this Amendment to be entered into by their duly authorised
representatives on the Amendment Signing Date and with validity as from the Amendment Effective Date. This Amendment may be executed in two (2) counterparts, in English language, each to the same effect, in the place and on the date last below
written. Signatures to this Amendment transmitted by email in “portable document format” (“pdf”), or by any other electronic means intended to preserve the original graphic and pictorial appearance of this Amendment shall have
the same effect as physical delivery of the paper document bearing original signature. 
  

			
	APR APPLIED PHARMA RESEARCH S.A.:
		
	BY:	 	/s/ Paolo Galfetti
		
	Name:	 	Paolo Galfetti
		
	Title:	 	CEO
		
	Date:	 	17.03.2021

  

									
	Arvato Services Italia srl	 		 	Arvato Services Italia srl
					
	BY:	 	/s/ Martin Zöckler	 		 	BY:	 	/s/ Antonio Amati
					
	Name:	 	Martin Zöckler	 		 	Name:	 	Antonio Amati
					
	Title:	 	HC BU Director	 		 	Title:	 	CEO
					
	Date:	 	15.03.2021	 		 	Date:	 	15.03.2021

  
 4EX-10.7(C)

 Exhibit 10.7(C) 

CERTAIN CONFIDENTIAL INFORMATION INDICATED BY “[***]” HAS BEEN OMITTED FROM THE FILED COPY OF THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT
MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED 
 Amendment no. 2 

to the Master Service Agreement on Order to Cash Service 

This Amendment N. 2 (hereinafter the “Amendment 2”) to the Master Service Agreement on Order to cash Service with an effective date of 1st
September 2018, is made on this July 13th, 2021 (the “Amendment 2 Effective Date”) by and between: 
 APR APPLIED PHARMA
RESEARCH S.A., a Swiss corporation, having its registered office at Via Corti, 5, 6828 Balerna, Switzerland (“APR”); 
 AND 

ARVATO SERVICES ITALIA SRL a corporation having its registered office at Via Zanica, 19K, 24050 Grassobbio (BG), Italy
(“ARVATO”) 
 Each of the above is a “Party” and together referred to herein as the “Parties”. 

Preamble 
  

	 	•	 	 APR and ARVATO entered into a Master Service Agreement on Order to Cash Service dated September 1st, 2018 (the
“Main Agreement”). 

  

	 	•	 	 On March 1st 2021 and with retroactive effect as of February 15th, 2021, the Parties entered into a first
amendment to the Agreement (the “Amendment”). 

  

	 	•	 	 For the purpose of this Amendment 2, the Main Agreement and the Amendment are jointly referred to as the
“Agreement”. 

  

	 	•	 	 Through the Amendment the Parties agreed to extend the renegotiation period provided at Section 19 par
(2) of the Main Agreement to the term of July 1st, 2021, within which the Parties were supposed to reach an agreement on any modification of the Agreement. 

 

	 	•	 	 The Parties have agreed about some changes to the terms of the Agreement and intend to introduce them through
this Amendment 2. The Parties additionally intend to amend the Term of the Agreement, by referring to the expiry date of December 31st, 2023 and providing automatic renewal periods subject to termination notice of any Party. Finally the Parties
intend to include through this Amendment 2 Arvato’s obligation to comply with APR’s Code of Ethics. 

Amendment 2 Terms and Conditions 
  

	1.	 Amendment of the Schedule D (Agreement terms renegotiation). It is agreed between the
Parties that as of the Amendment 2 Effective Date the Schedule D of the Agreement shall be replaced with the Schedule D to this Amendment 2 attached herein. For the sake of clarity, the entity and cost of the monthly position elements reported in
the Schedule D shall be determined in accordance with the applicable timelines and related prices detailed in the same Schedule D. 

	2.	 Amendment of Article 19, par (1) and par (2) (Amendment of
the Term and automatic renewal). The Parties agree that as of the Amendment 2 Effective Date, the Article 19, par (1) and par (2) of the Agreement shall be replaced with the Article 19, par (1) and par (2) of this
Amendment 2 as follows: 

 “(1) This Agreement and all related Schedules, Exhibits, Amendments and Annexes attached
hereto shall come into force on the Effective Date and shall be valid until the term of December 31st, 2023. (the “Term”)” 

(2)The Agreement shall be automatically renewed for 1 (one) calendar year periods, unless each Party earlier terminates it prior 6 (six)
months written notice. For the sake of clarity, upon renewal of the Agreement for any calendar year period, any reference to the Term contained in the Agreement shall be supposed to include such calendar year.” 

 

	3.	 Amendment to Article 3, par (2). (Inclusion of APR’s Code of Ethics) 

The Parties agree that as of the Amendment 2 Effective Date, the Article 3, par (2) of the Agreement shall be replaced with the Article 3,
par (2) of this Amendment 2 as follows: 
 “(2) Arvato shall act in accordance with Applicable Law, GDP and HACCP at a standard
to be expected from a reputable, specialized and professional logistics provider in the pharmaceutical and food sectors. Arvato shall perform its activities in respect of the content of APR’ Code of Ethics v. 1.0 of October 2018, which Arvato
represents to have received and understood, and any of its updates duly provided by APR during the Term.” 
 Miscellaneous

 Capitalized terms not otherwise defined herein shall have the meaning given to them in the Agreement. Except as modified below, the terms of the
Agreement shall remain in full force and effect. 
 Except where the context requires otherwise, references in this Amendment 2 to the Agreement are to the
Agreement as amended by, and including, this Amendment 2. 
 AS WITNESS hereto the Parties have caused this Amendment 2 to be entered into by their duly
authorised representatives on the Amendment 2 Effective Date. This Amendment may be executed in two (2) counterparts, in English language, each to the same effect, in the place and on the date last below written. Signatures to this Amendment 2
transmitted by email in “portable document format” (“pdf”), or exchange of electronic signatures shall have the same effect as physical delivery of the paper document bearing original signature. 

  
 2 

			
	Apr Applied Pharma Research
		
	BY:	 	/s/ Paolo Galfetti
	Name: Paolo Galfetti
	Title: CEO
	
	Date: 25.10.2021

  

									
	Arvato Services Italia srl	 		 	Arvato Services Italia srl
					
	BY:	 	/s/ Martin Zöeckler	 		 	BY:	 	/s/ Antonio Amati
	Name: Martin Zöeckler	 		 	Name: Antonio Amati
	Title: Bu. Director	 		 	Title: CEO
			
	Date: 20/10/2021	 		 	Date: 20/10/2021

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]